PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Actinobacillus Infections D000189 4 associated lipids
Adenocarcinoma D000230 166 associated lipids
Alzheimer Disease D000544 76 associated lipids
Anal Gland Neoplasms D000694 1 associated lipids
Anaphylaxis D000707 35 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Ascariasis D001196 3 associated lipids
Asthma D001249 52 associated lipids
Astrocytoma D001254 15 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Blister D001768 16 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Body Weight D001835 333 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Bronchial Spasm D001986 18 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Wang P et al. The antagonistic actions of endogenous interleukin-1β and 15-deoxy-Δ12,14-prostaglandin J2 regulate the temporal synthesis of matrix metalloproteinase-9 in sheared chondrocytes. 2012 J. Biol. Chem. pmid:22829602
Tokumoto H et al. An NADP-linked 15-hydroxyprostaglandin dehydrogenase specific for prostaglandin D2 from swine brain. 1982 J. Biol. Chem. pmid:6958674
Nelson SM et al. Selenoprotein Expression in Macrophages Is Critical for Optimal Clearance of Parasitic Helminth Nippostrongylus brasiliensis. 2016 J. Biol. Chem. pmid:26644468
Mathurin K et al. An interaction between L-prostaglandin D synthase and arrestin increases PGD2 production. 2011 J. Biol. Chem. pmid:21112970
Jiang JG et al. Peroxisome proliferator-activated receptor gamma-mediated transcriptional up-regulation of the hepatocyte growth factor gene promoter via a novel composite cis-acting element. 2001 J. Biol. Chem. pmid:11292834
Cheng S et al. Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1. 2004 J. Biol. Chem. pmid:15023995
Kawamoto Y et al. Cyclopentenone prostaglandins as potential inducers of phase II detoxification enzymes. 15-deoxy-delta(12,14)-prostaglandin j2-induced expression of glutathione S-transferases. 2000 J. Biol. Chem. pmid:10753940
Alvarez-Maqueda M et al. 15-deoxy-delta 12,14-prostaglandin J2 induces heme oxygenase-1 gene expression in a reactive oxygen species-dependent manner in human lymphocytes. 2004 J. Biol. Chem. pmid:15024026
Nie M et al. Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists. 2005 J. Biol. Chem. pmid:15531761
Shimizu T et al. Specific binding of prostaglandin D2 to rat brain synaptic membrane. Occurrence, properties, and distribution. 1982 J. Biol. Chem. pmid:6292197
Eling TE et al. Oxidation of glutathione to its thiyl free radical metabolite by prostaglandin H synthase. A potential endogenous substrate for the hydroperoxidase. 1986 J. Biol. Chem. pmid:3007487
Koizumi T et al. Identification of a cis-regulatory element for delta 12-prostaglandin J2-induced expression of the rat heme oxygenase gene. 1995 J. Biol. Chem. pmid:7665598
Wang YL et al. Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival. 2002 J. Biol. Chem. pmid:12082115
Hirata Y et al. Occurrence of 9-deoxy-delta 9,delta 12-13,14-dihydroprostaglandin D2 in human urine. 1988 J. Biol. Chem. pmid:3053696
Wilhelm D et al. SOX9 regulates prostaglandin D synthase gene transcription in vivo to ensure testis development. 2007 J. Biol. Chem. pmid:17277314
Amir-Moazami O et al. Phospholipid scramblase 1 modulates a selected set of IgE receptor-mediated mast cell responses through LAT-dependent pathway. 2008 J. Biol. Chem. pmid:18579528
Lapointe DS and Olson MS Platelet-activating factor-stimulated hepatic glycogenolysis is not mediated through cyclooxygenase-derived metabolites of arachidonic acid. 1989 J. Biol. Chem. pmid:2501299
Urade Y et al. Mast cells contain spleen-type prostaglandin D synthetase. 1990 J. Biol. Chem. pmid:2403560
Bishop-Bailey D and Hla T Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2. 1999 J. Biol. Chem. pmid:10358055
Kwon G et al. Tumor necrosis factor alpha-induced pancreatic beta-cell insulin resistance is mediated by nitric oxide and prevented by 15-deoxy-Delta12,14-prostaglandin J2 and aminoguanidine. A role for peroxisome proliferator-activated receptor gamma activation and inos expression. 1999 J. Biol. Chem. pmid:10373483
Lee TS et al. Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta 12,14-prostaglandin J2. 2003 J. Biol. Chem. pmid:12642589
Richman JG et al. Nicotinic acid receptor agonists differentially activate downstream effectors. 2007 J. Biol. Chem. pmid:17452318
Baek SJ et al. Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1. 2004 J. Biol. Chem. pmid:14662774
Schröder R et al. The C-terminal tail of CRTH2 is a key molecular determinant that constrains Galphai and downstream signaling cascade activation. 2009 J. Biol. Chem. pmid:19010788
Ho TC et al. 15-deoxy-Delta(12,14)-prostaglandin J2 induces vascular endothelial cell apoptosis through the sequential activation of MAPKS and p53. 2008 J. Biol. Chem. pmid:18718914
Liston TE and Roberts LJ Metabolic fate of radiolabeled prostaglandin D2 in a normal human male volunteer. 1985 J. Biol. Chem. pmid:3863815
Hosoya T et al. Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells. 2005 J. Biol. Chem. pmid:15917255
Chen Y et al. Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway. 1999 J. Biol. Chem. pmid:10196163
Xin X et al. Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo. 1999 J. Biol. Chem. pmid:10085162
Gao L et al. Formation of prostaglandins E2 and D2 via the isoprostane pathway: a mechanism for the generation of bioactive prostaglandins independent of cyclooxygenase. 2003 J. Biol. Chem. pmid:12746435
Pérez-Sala D et al. Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-Delta 12,14-prostaglandin J2. 2003 J. Biol. Chem. pmid:14532268
Worley JR et al. Metalloproteinase expression in PMA-stimulated THP-1 cells. Effects of peroxisome proliferator-activated receptor-gamma (PPAR gamma) agonists and 9-cis-retinoic acid. 2003 J. Biol. Chem. pmid:14534304
Lee S et al. Lipocalin-type prostaglandin D2 synthase protein regulates glial cell migration and morphology through myristoylated alanine-rich C-kinase substrate: prostaglandin D2-independent effects. 2012 J. Biol. Chem. pmid:22275363
Shibata T et al. Thioredoxin as a molecular target of cyclopentenone prostaglandins. 2003 J. Biol. Chem. pmid:12709421
Murakami M et al. Prostaglandin endoperoxide synthase-1 and -2 couple to different transmembrane stimuli to generate prostaglandin D2 in mouse bone marrow-derived mast cells. 1994 J. Biol. Chem. pmid:8071353
Shan ZZ et al. A potential role of 15-deoxy-delta(12,14)-prostaglandin J2 for induction of human articular chondrocyte apoptosis in arthritis. 2004 J. Biol. Chem. pmid:15213234
Fitzpatrick FA and Wynalda MA Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. 1983 J. Biol. Chem. pmid:6578214
Pugliese G et al. Hepatic transformation of prostaglandin D2 to a new prostanoid, 9 alpha,11 beta-prostaglandin F2, that inhibits platelet aggregation and constricts blood vessels. 1985 J. Biol. Chem. pmid:3863819
Clay CE et al. Early de novo gene expression is required for 15-deoxy-Delta 12,14-prostaglandin J2-induced apoptosis in breast cancer cells. 2001 J. Biol. Chem. pmid:11668172
Hilliard M et al. The anti-inflammatory prostaglandin 15-deoxy-delta(12,14)-PGJ2 inhibits CRM1-dependent nuclear protein export. 2010 J. Biol. Chem. pmid:20457605
Paruchuri S et al. Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells. 2008 J. Biol. Chem. pmid:18411276
Shiraya K et al. A novel transporter of SLC22 family specifically transports prostaglandins and co-localizes with 15-hydroxyprostaglandin dehydrogenase in renal proximal tubules. 2010 J. Biol. Chem. pmid:20448048
Guo N et al. Mast cell-derived prostaglandin D2 controls hyaluronan synthesis in human orbital fibroblasts via DP1 activation: implications for thyroid eye disease. 2010 J. Biol. Chem. pmid:20308056
Ishimoto T et al. Importance of the phospholipase D-initiated sequential pathway for arachidonic acid release and prostaglandin D2 generation by rat peritoneal mast cells. 1996 J. Biochem. pmid:8902628
Kimura K et al. Modulation of platelet activating factor-induced glycogenolysis in the perfused rat liver after administration of endotoxin in vivo. 1998 J. Biochem. pmid:9504421
Matsumoto K et al. Novel function of prostaglandins as inducers of gene expression of HGF and putative mediators of tissue regeneration. 1995 J. Biochem. pmid:7608139
Sakamoto H et al. Effect of intracellular glutathione on the production of prostaglandin D2 in RBL-2H3 cells oxidized by tert-butyl hydroperoxide. 1999 J. Biochem. pmid:9880802
Irikura D et al. Cloning, expression, crystallization, and preliminary X-ray analysis of recombinant mouse lipocalin-type prostaglandin D synthase, a somnogen-producing enzyme. 2003 J. Biochem. pmid:12761195
Spatz M et al. Vasoactive peptides and prostaglandin D2 in human cerebromicrovascular endothelium. 1994 J. Auton. Nerv. Syst. pmid:7836668
Hardy CC et al. Bronchoconstrictor and antibronchoconstrictor properties of inhaled prostacyclin in asthma. 1988 J. Appl. Physiol. pmid:3288608
Cummings JJ Pulmonary vasodilator drugs decrease lung liquid production in fetal sheep. 1995 J. Appl. Physiol. pmid:8567564
Hayaishi O Molecular genetic studies on sleep-wake regulation, with special emphasis on the prostaglandin D(2) system. 2002 J. Appl. Physiol. pmid:11796702
Phillips GD and Holgate ST Interaction of inhaled LTC4 with histamine and PGD2 on airway caliber in asthma. 1989 J. Appl. Physiol. pmid:2917934
Fredberg JJ et al. Tissue resistance and the contractile state of lung parenchyma. 1993 J. Appl. Physiol. pmid:8482682
Kleeberger SR et al. Central role of cyclooxygenase in the response of canine peripheral airways to antigen. 1986 J. Appl. Physiol. pmid:2430928
Emery DL et al. Prostaglandin D2 causes accumulation of eosinophils in the lumen of the dog trachea. 1989 J. Appl. Physiol. pmid:2793725
Serio R and Daniel EE Thromboxane effects on canine trachealis neuromuscular function. 1988 J. Appl. Physiol. pmid:2839451
Underwood DC et al. Blockade of thromboxane responses in the airway of the cat by SQ 29,548. 1987 J. Appl. Physiol. pmid:2440845
Beasley RC et al. Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction. 1989 J. Appl. Physiol. pmid:2525122
Tilden SJ et al. Effects of OKY 1581 on bronchoconstrictor responses to arachidonic acid and PGH2. 1987 J. Appl. Physiol. pmid:2954941
Myers AC et al. Influence of antigen on membrane properties of guinea pig bronchial ganglion neurons. 1991 J. Appl. Physiol. pmid:1721906
Walmrath D et al. Intravascular anti-IgE challenge in perfused lungs: mediator release and vascular pressor response. 1991 J. Appl. Physiol. pmid:1723406
Rajakulasingam K et al. Interactive effect of inhaled bradykinin with histamine and PGD2 in bronchial asthma. 1993 J. Appl. Physiol. pmid:8307852
McMahon TJ et al. Influence of SQ 30741 on thromboxane receptor-mediated responses in the feline pulmonary vascular bed. 1991 J. Appl. Physiol. pmid:1837015
Tamaoki J et al. Cholinergic neuromodulation by prostaglandin D2 in canine airway smooth muscle. 1987 J. Appl. Physiol. pmid:2891674
Piprek RP Genetic mechanisms underlying male sex determination in mammals. 2009 J. Appl. Genet. pmid:19875885
Tsutsumi S et al. Cerebrospinal fluid drainage through the diploic and spinal epidural veins. 2015 J. Anat. pmid:26184099
Stamatakis K et al. Identification of novel protein targets for modification by 15-deoxy-Delta12,14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton. 2006 J. Am. Soc. Nephrol. pmid:16291835
Ito H et al. PGD2-CRTH2 pathway promotes tubulointerstitial fibrosis. 2012 J. Am. Soc. Nephrol. pmid:22997255
Ruan XZ et al. PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. 2003 J. Am. Soc. Nephrol. pmid:12595494
Arici M et al. Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-gamma. 2003 J. Am. Soc. Nephrol. pmid:12506134
Rovin BH et al. Cyclopentenone prostaglandins inhibit cytokine-induced nf-kappab activation and chemokine production by human mesangial cells. 2001 J. Am. Soc. Nephrol. pmid:11461938
Li Y et al. Prediction of the 3D structure and dynamics of human DP G-protein coupled receptor bound to an agonist and an antagonist. 2007 J. Am. Chem. Soc. pmid:17691773
Yamaguchi S et al. Delta12-prostaglandin J2 as a product and ligand of human serum albumin: formation of an unusual covalent adduct at His146. 2010 J. Am. Chem. Soc. pmid:20014793
VanderEnde DS and Morrow JD Release of markedly increased quantities of prostaglandin D2 from the skin in vivo in humans after the application of cinnamic aldehyde. 2001 J. Am. Acad. Dermatol. pmid:11423836
Reddy PH Inhibitors of mitochondrial fission as a therapeutic strategy for diseases with oxidative stress and mitochondrial dysfunction. 2014 J. Alzheimers Dis. pmid:24413616
Ahluwalia P et al. Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms. 2001 J. Allergy Clin. Immunol. pmid:11544467
van der Linden PW et al. Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation. 1992 J. Allergy Clin. Immunol. pmid:1629497
Pienkowski MM et al. Prostaglandin D2 and histamine during the immediate and the late-phase components of allergic cutaneous responses. 1988 J. Allergy Clin. Immunol. pmid:3292634
Gervais FG et al. Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. 2001 J. Allergy Clin. Immunol. pmid:11742277
Ruzicka T et al. Inhibition of rat mast cell arachidonic acid cyclooxygenase by dapsone. 1983 J. Allergy Clin. Immunol. pmid:6413566
Johnston SL et al. The effect of BAY u 3405, a thromboxane receptor antagonist, on prostaglandin D2-induced nasal blockage. 1993 J. Allergy Clin. Immunol. pmid:8473679
Schleimer RP et al. Role of human basophils and mast cells in the pathogenesis of allergic diseases. 1985 J. Allergy Clin. Immunol. pmid:2410478
Emery BE et al. The effect of IL-4 on human nasal mucosal responses. 1992 J. Allergy Clin. Immunol. pmid:1430703
Fajt ML et al. Prostaglandin Dâ‚‚ pathway upregulation: relation to asthma severity, control, and TH2 inflammation. 2013 J. Allergy Clin. Immunol. pmid:23506843
Schulman ES et al. Density heterogeneity of human lung mast cells. 1988 J. Allergy Clin. Immunol. pmid:2455745
Shichijo M et al. Role of cyclic 3',5'-adenosine monophosphate in the regulation of chemical mediator release and cytokine production from cultured human mast cells. 1999 J. Allergy Clin. Immunol. pmid:10329844
Bochner BS et al. Interleukin-1 is released at sites of human cutaneous allergic reactions. 1990 J. Allergy Clin. Immunol. pmid:2262641
Doyle WJ et al. Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy. 1990 J. Allergy Clin. Immunol. pmid:2262647
Xue L et al. Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. 2014 J. Allergy Clin. Immunol. pmid:24388011
Norman PS The John Sheldon memorial lecture. Review of nasal therapy: update. 1983 J. Allergy Clin. Immunol. pmid:6195204
Bochenek G et al. A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge. 2003 J. Allergy Clin. Immunol. pmid:12704352
Szczeklik W et al. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. 2004 J. Allergy Clin. Immunol. pmid:15316498
Schleimer RP et al. Inflammatory mediators and mechanisms of release from purified human basophils and mast cells. 1984 J. Allergy Clin. Immunol. pmid:6208229
Nakahigashi K et al. PGD2 induces eotaxin-3 via PPARγ from sebocytes: a possible pathogenesis of eosinophilic pustular folliculitis. 2012 J. Allergy Clin. Immunol. pmid:22206772
Raphael GD et al. The pathophysiology of rhinitis. V. Sources of protein in allergen-induced nasal secretions. 1991 J. Allergy Clin. Immunol. pmid:1712803
Awad JA et al. Detection of the major urinary metabolite of prostaglandin D2 in the circulation: demonstration of elevated levels in patients with disorders of systemic mast cell activation. 1994 J. Allergy Clin. Immunol. pmid:8182221
Salari H et al. Involvement of immunologic mechanisms in a guinea pig model of western red cedar asthma. 1994 J. Allergy Clin. Immunol. pmid:8182231
Proud D et al. Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen. 1990 J. Allergy Clin. Immunol. pmid:1692049
Miadonna A et al. Mediator release after endobronchial antigen challenge in patients with respiratory allergy. 1990 J. Allergy Clin. Immunol. pmid:1692050